Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease.
Xianjun DongYun-Fei BaiZhixiang LiaoDavid GritschXiaoli LiuTao WangRebeca Borges-MonroyAlyssa EhrlichGeidy E SeranoMel B FeanyThomas G BeachClemens R ScherzerPublished in: bioRxiv : the preprint server for biology (2023)
Little is known about circular RNAs (circRNAs) in specific brain cells and human neuropsychiatric disease. Here, we systematically identified over 11,039 circRNAs expressed in vulnerable dopamine and pyramidal neurons laser-captured from 190 human brains and non-neuronal cells using ultra-deep, total RNA sequencing. 1,526 and 3,308 circRNAs were custom-tailored to the cell identity of dopamine and pyramidal neurons and enriched in synapse pathways. 88% of Parkinson's and 80% of Alzheimer's disease-associated genes produced circRNAs. circDNAJC6, produced from a juvenile-onset Parkinson's gene, was already dysregulated during prodromal, onset stages of common Parkinson's disease neuropathology. Globally, addiction-associated genes preferentially produced circRNAs in dopamine neurons, autism-associated genes in pyramidal neurons, and cancers in non-neuronal cells. This study shows that circular RNAs in the human brain are tailored to neuron identity and implicate circRNA- regulated synaptic specialization in neuropsychiatric diseases.
Keyphrases
- induced apoptosis
- cell cycle arrest
- spinal cord
- genome wide
- endothelial cells
- single cell
- signaling pathway
- cell death
- genome wide identification
- endoplasmic reticulum stress
- mesenchymal stem cells
- cerebral ischemia
- genome wide analysis
- pi k akt
- spinal cord injury
- transcription factor
- smoking cessation
- stem cells
- induced pluripotent stem cells
- intellectual disability
- multiple sclerosis
- uric acid
- cell therapy
- copy number
- high speed
- mild cognitive impairment
- pluripotent stem cells
- white matter
- bioinformatics analysis
- cognitive decline